Abanoquil, a new alpha-1 adrenoceptor antagonist. In vitro and in vivo effect on erectile tissue. 2000

Giraldi, and Wyllie, and Wagner
Department of Medical Physiology, University of Copenhagen, Rigshospitalet, 7121, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.

Using an organ bath model with porcine cavernosal tissue strips and an in vivo monkey model we demonstrated that abanoquil, a novel alpha adrenoceptor antagonist, is able to relax contracted tissue strips and induce erectile response when injected intracorporally. The erectile response in the monkeys was not dose-related and compared to the effect of papaverine injections, abanoquil induced a lower level of tumescence and rigidity. Hence, abanoquil might be useful as a facilitator of erection in the pharmacological treatment of erectile dysfunction. International Journal of Impotence Research (2000) 12, Suppl 1, S37-S40

UI MeSH Term Description Entries

Related Publications

Giraldi, and Wyllie, and Wagner
September 1990, European journal of pharmacology,
Giraldi, and Wyllie, and Wagner
April 1983, Naunyn-Schmiedeberg's archives of pharmacology,
Giraldi, and Wyllie, and Wagner
October 1995, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Giraldi, and Wyllie, and Wagner
July 1988, Japanese journal of pharmacology,
Giraldi, and Wyllie, and Wagner
April 2000, European journal of pharmacology,
Giraldi, and Wyllie, and Wagner
October 1990, British journal of clinical pharmacology,
Copied contents to your clipboard!